<DOC>
	<DOCNO>NCT02915406</DOCNO>
	<brief_summary>This protocol design enable access relate unrelated CD34 cell manufacture use CliniMACS ( Miltenyi ) HUD designation patient need T cell deplete allogeneic graft hematopoietic stem cell transplant ( HSCT ) . This include patient inherited immunodeficiency disorder well patient malignancy , bone marrow failure , rare disease amenable HSCT . Finally , patient poor graft function Graft Versus Host Disease ( GVHD ) previous HSCT may require boost T-cell depleted donor Peripheral Blood Stem Cell ( PBSCs ) bone marrow cell CD34 select use CliniMACS device ENROLLMENT BY INVITATION ONLY</brief_summary>
	<brief_title>cliniMACs HUD T Cell Depletion</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>X-Linked Combined Immunodeficiency Diseases</mesh_term>
	<criteria>severe combine immune deficiency need stem cell boost</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>